Stay updated on Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.

Latest updates to the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page
- Check5 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.0 implemented, replacing v3.4.3. No study content changes are visible.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing v3.4.2. This appears to be a minor version update without changes to study content or user-facing features.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoval of metadata topics 'Head and neck squamous cell carcinoma' and related terms like 'MedlinePlus Genetics' from the page may affect indexing and search filters, but does not change the trial content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check69 days agoChange DetectedAdds contextual tags such as 'Head and neck squamous cell carcinoma' and related topic links (MedlinePlus Genetics) and updates revision notes; removes a government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check76 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH Clinical Center operations, and updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.